Key opportunities in the precision oncology market include the rising adoption of personalized therapies, growth in ...
Founded by former Illumina, Grail and Google leaders, Hepta is applying the technological, genomic and commercialization expertise that made liquid biopsy possible in oncology to the far larger field ...
According to Mordor Intelligence, the global companion diagnostics market is valued at USD 8.70 billion in 2025 and is projected to surpass USD 15.62 billion by 2030, growing at a CAGR of 12.42% ...
According to Mordor Intelligence, the global companion diagnostics market is valued at USD 8.70 billion in 2025 and is projected to surpass ...
Illumina Inc. said the Chinese government has lifted a ban on the company selling its DNA sequencing machines inside the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results